This event is archived. Final snapshot from when the story concluded. View on Dashboard
Events / Business / Trevi Therapeutics Announces Event Schedule
Business conference attendance

Trevi Therapeutics Announces Event Schedule

Analysis based on 6 articles · First reported Jun 17, 2026 · Last updated Jun 17, 2026

Sentiment
10
Attention
2
Articles
6
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard
Market Impact

The market impact is likely minimal, as this is a routine announcement of conference attendance. However, it provides visibility for Trevi Therapeutics and its investigational therapy Haduvio, potentially generating interest among investors and industry participants.

Biotechnology Pharmaceuticals
Event Summary

Trevi Therapeutics, a clinical-stage biopharmaceutical company, announced that its senior management will attend several upcoming industry events in June and July 2026. These events include the BIO International Convention, Leerink Partners Therapeutics Forum 2026, and ERS Cough Conference 2026. Representatives such as Jennifer Good, Simon Farrell, Reed Hastings, and James Cassella will be present to discuss the company's investigational therapy, Haduvio, which is being developed for chronic cough in patients with idiopathic pulmonary fibrosis, non-IPF interstitial lung disease, and refractory chronic cough.

Entities Involved
stock
Trevi Therapeutics
Trevi Therapeutics is announcing its participation in several upcoming industry conferences to present its investigational therapy Haduvio.
Importance 100.0 Sentiment 10.0
per
Jennifer Good
Jennifer Good, President and CEO of Trevi Therapeutics, will represent the company at the BIO International Convention and ERS Cough Conference.
Importance 70.0 Sentiment 0.0
per
Simon Farrell
Simon Farrell, CCO of Trevi Therapeutics, will represent the company at the BIO International Convention and Leerink Partners Therapeutics Forum.
Importance 70.0 Sentiment 0.0
per
Reed Hastings
Reed Hastings, CFO of Trevi Therapeutics, will represent the company at the Leerink Partners Therapeutics Forum.
Importance 70.0 Sentiment 0.0
per
James Cassella
James Cassella, CDO of Trevi Therapeutics, will represent the company at the ERS Cough Conference.
Importance 70.0 Sentiment 0.0
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.